Hunan Jiudian Pharmaceutical Co., Ltd. (SHE: 300705)

Market Cap	10.13B
Revenue (ttm)	2.84B
Net Income (ttm)	454.76M
Shares Out	486.53M
EPS (ttm)	0.94
PE Ratio	22.17
Forward PE	19.65
Dividend	0.23 (1.09%)
Ex-Dividend Date	May 24, 2024

Volume	2,438,974
Open	21.96
Previous Close	21.11
Day's Range	20.66 - 21.96
52-Week Range	14.66 - 28.36
Beta	0.48
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Hunan Jiudian Pharmaceutical

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its leading products are loxoprofen sodium gel plaster and hydrochloric acid. The company offers its products in the anti-inflammatory and analgesic, anti-infective, anti-allergic, digestive system, cardiovascular and cerebrovascular, gynecological drugs, supplements, and other fields. The company was founded in 2001 and is based in Changsha, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 1,893
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300705

Financial Performance

In 2023, Hunan Jiudian Pharmaceutical's revenue was 2.69 billion, an increase of 15.75% compared to the previous year's 2.33 billion. Earnings were 368.26 million, an increase of 36.54%.